Lovastatin
Cat# M1575-10mg
Size : 10mg
Brand : AbMole Bioscience
MK-803; Mevinolin
Quality Control & Documentation
Biological Activity
Lovastatin is an inhibitor of HMG-CoA reductase with IC50 of 3.4 nM in a cell-free assay, used for lowering cholesterol (hypolipidemic agent).
Product Citations
-
Pak J Pharm Sci. 2016 May;29(3 Suppl):1043-51.
Chromatographic resolution of drug analogues: 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins)
Lovastatin purchased from AbMole
Customer Product Validations & Biological Datas
Source | Pak J Pharm Sci (2016). Figure 1. Lovastatin (Abmole Bioscience) | |
Method | HPLC chromatogram | |
Cell Lines | ||
Concentrations | 200μg/ml | |
Incubation Time | ||
Results | The results summarized in (table 1) obtained for pravastatin, rosuvastatin, pitavastatin, atorvastatin, fluvastatin, lovastatin and simvastatin were comparable with the corresponding labeled amounts. |
Chemical Information
Molecular Weight | 404.54 |
Formula | C24H36O5 |
CAS Number | 75330-75-5 |
Solubility (25°C) | DMSO ≥ 60 mg/mL |
Storage | Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Conversion of different model animals based on BSA (PMID: 27057123)
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
References
[1] Nazish Sayed, et al. Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy
[2] Yaru Zhang, et al. An overview on the biosynthesis and metabolic regulation of monacolin K/lovastatin
[3] Zixiao Xiong, et al. An overview of the bioactivity of monacolin K / lovastatin
[4] Kelly C L Mulder, et al. Lovastatin production: From molecular basis to industrial process optimization
[5] F P Zeller, et al. Lovastatin for hypercholesterolemia